CP
TMO icon

Cumberland Partners’s Thermo Fisher Scientific TMO Stock Holding History

Cumberland Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-850
Closed -$345K – 189
2025
Q2 		$345K Sell
850
-33,573
-98% -$14M 0.02% 159
2025
Q1 		$17.1M Sell
34,423
-272
-0.8% -$147K 1.32% 24
2024
Q4 		$18M Sell
34,695
-73
-0.2% -$40.1K 1.26% 25
2024
Q3 		$21.5M Sell
34,768
-14,600
-30% -$8.64M 1.49% 22
2024
Q2 		$27.3M Sell
49,368
-1,369
-3% -$784K 1.99% 18
2024
Q1 		$29.5M Buy
50,737
+877
+2% +$492K 2.14% 18
2023
Q4 		$25.3M Sell
49,860
-745
-1% -$361K 2.31% 17
2023
Q3 		$25.6M Sell
50,605
-1,213
-2% -$646K 2.46% 17
2023
Q2 		$27M Sell
51,818
-715
-1% -$386K 2.48% 15
2023
Q1 		$30.3M Sell
52,533
-922
-2% -$520K 2.97% 9
2022
Q4 		$29.4M Sell
53,455
-4,022
-7% -$2.13M 3.1% 9
2022
Q3 		$29.2M Buy
57,477
+2,080
+4% +$1.16M 3.1% 8
2022
Q2 		$30.1M Sell
55,397
-3,333
-6% -$1.83M 2.87% 10
2022
Q1 		$34.7M Buy
58,730
+95
+0.2% +$54.6K 2.62% 11
2021
Q4 		$39.1M Buy
58,635
+2,415
+4% +$1.51M 2.75% 7
2021
Q3 		$32.1M Buy
56,220
+794
+1% +$436K 2.63% 8
2021
Q2 		$28M Sell
55,426
-3,918
-7% -$1.85M 2.19% 10
2021
Q1 		$27.1M Sell
59,344
-1,023
-2% -$488K 2.23% 12
2020
Q4 		$28.1M Sell
60,367
-1,214
-2% -$569K 2.52% 10
2020
Q3 		$27.2M Buy
61,581
+1,363
+2% +$563K 2.84% 9
2020
Q2 		$21.8M Buy
60,218
+2,657
+5% +$891K 2.26% 12
2020
Q1 		$16.3M Sell
57,561
-2,343
-4% -$739K 1.96% 17
2019
Q4 		$19.5M Buy
59,904
+403
+0.7% +$122K 1.73% 20
2019
Q3 		$17.3M Buy
59,501
+18,335
+45% +$5.25M 1.67% 23
2019
Q2 		$12.1M Buy
+41,166
New +$11.3M 1.16% 28

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cumberland Partners's TMO Position: Q3 2025 in Review

Cumberland Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 850 shares — an estimated $345K sold.

Cumberland Partners first reported a position in TMO in Q2 2019 and held it in 25 quarters. The position peaked at $39.1M in Q4 2021. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Cumberland Partners reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Cumberland Partners sold 850 Thermo Fisher Scientific shares in Q3 2025, an estimated $345K.
  • Cumberland Partners first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 25 quarters.
  • Cumberland Partners's Thermo Fisher Scientific position peaked at $39.1M in Q4 2021.
  • 2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Cumberland Partners's 13F filing for Q3 2025, filed 7 Nov 2025.